Eads & Heald Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,756
| Closed | -$259K | – | 148 |
|
|
2022
Q2 | $259K | Sell |
4,756
-4
| -0.1% | -$218 | 0.14% | 137 |
|
|
2022
Q1 | $259K | Sell |
4,760
-7
| -0.1% | -$381 | 0.12% | 133 |
|
|
2021
Q4 | $263K | Buy |
4,767
+117
| +3% | +$6.46K | 0.11% | 137 |
|
|
2021
Q3 | $222K | Buy |
+4,650
| New | +$222K | 0.11% | 138 |
|
|
2017
Q4 | – | Sell |
-4,998
| Closed | -$254K | – | 130 |
|
|
2017
Q3 | $254K | Sell |
4,998
-19
| -0.4% | -$966 | 0.16% | 120 |
|
|
2017
Q2 | $270K | Sell |
5,017
-2
| -0% | -$108 | 0.17% | 119 |
|
|
2017
Q1 | $265K | Sell |
5,019
-460
| -8% | -$24.3K | 0.17% | 117 |
|
|
2016
Q4 | $264K | Sell |
5,479
-240
| -4% | -$11.6K | 0.18% | 118 |
|
|
2016
Q3 | $308K | Buy |
5,719
+36
| +0.6% | +$1.94K | 0.21% | 117 |
|
|
2016
Q2 | $308K | Sell |
5,683
-48
| -0.8% | -$2.6K | 0.21% | 115 |
|
|
2016
Q1 | $291K | Buy |
5,731
+154
| +3% | +$7.82K | 0.2% | 118 |
|
|
2015
Q4 | $281K | Sell |
5,577
-1,936
| -26% | -$97.5K | 0.19% | 122 |
|
|
2015
Q3 | $361K | Sell |
7,513
-392
| -5% | -$18.8K | 0.26% | 115 |
|
|
2015
Q2 | $412K | Buy |
7,905
+692
| +10% | +$36.1K | 0.27% | 112 |
|
|
2015
Q1 | $416K | Buy |
7,213
+300
| +4% | +$17.3K | 0.27% | 110 |
|
|
2014
Q4 | $369K | Buy |
+6,913
| New | +$369K | 0.23% | 110 |
|
|
2014
Q3 | – | Sell |
-3,413
| Closed | -$228K | – | 125 |
|
|
2014
Q2 | $228K | Buy |
3,413
+45
| +1% | +$3.01K | 0.15% | 113 |
|
|
2014
Q1 | $225K | Buy |
+3,368
| New | +$225K | 0.15% | 112 |
|